Filing Flows › Bio-Rad Laboratories (BIO) › R&D spending
Bio-Rad Laboratories (BIO) R&D spending by quarter
Bio-Rad Laboratories' R&D spending was $71.4M in Q3 2026 (third quarter 2026), +17% from Q2 2026. Over the last 7 quarters it ranged from $60.5M (Q2 2025) to $73.5M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $71.4M | +17% | +0.1% |
| Q2 2026 | $61.2M | -3% | +1% |
| Q1 2026 | $62.9M | -11% | -14% |
| Q4 2025 | $70.3M | -1% | — |
| Q3 2025 | $71.3M | +18% | — |
| Q2 2025 | $60.5M | -18% | — |
| Q1 2025 | $73.5M | — | — |
Q3 2026 at a glance
Bio-Rad Laboratories, Q3 2026: revenue $656M (+0.5% year over year), operating margin -7.6%, net earnings $459M, operating cash flow $96.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Rad Laboratories' R&D spending?
Bio-Rad Laboratories' R&D spending was $71.4M in Q3 2026 (third quarter 2026), +17% from Q2 2026.
How has Bio-Rad Laboratories' R&D spending changed?
Over the last 7 quarters it ranged from $60.5M (Q2 2025) to $73.5M (Q1 2025).